PD-1 Blockade in Anaplastic Thyroid Carcinoma.

Jaume CapdevilaLori J WirthThomas ErnstSantiago Ponce AixChia-Chi LinRodryg RamlauMarcus O ButlerJean-Pierre DelordHans GelderblomPaolo A AsciertoAngelica FasoloDagmar FuhrerMarie Luise Hütter-KrönkePatrick M FordeAnna WronaArmando SantoroPeter M SadowSebastian SzpakowskiHongqian WuGeraldine BostelJason FarisScott CameronAndreea VargaMatthew Taylor

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020)

To our knowledge, this is the first clinical trial to show responsiveness of anaplastic thyroid carcinoma to PD-1 blockade.

Keyphrases

clinical trial
healthcare
phase ii
study protocol
open label
randomized controlled trial